HOME
ABOUT US
GEMINI
PIPELINE
INVESTORS
CONTACT
Back
Overview
Board
Management
Advisory Board
Back
Overview
Acute Kidney Injury (AKI)
Posters and Publications
Back
Overview
News
Events and Presentations
Filings
Stock
HOME
ABOUT US
Overview
Board
Management
Advisory Board
GEMINI
Overview
Acute Kidney Injury (AKI)
Posters and Publications
PIPELINE
INVESTORS
Overview
News
Events and Presentations
Filings
Stock
CONTACT
Scroll
REVB performance
by TradingView
News
News
November 5, 2026
Revelation Biosciences, Inc. Announces Financial Results For the Three and Nine Months Ended September 30, 2026
November 5, 2026
Read more →
November 5, 2026
October 16, 2026
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
October 16, 2026
Read more →
October 16, 2026
August 19, 2026
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
August 19, 2026
Read more →
August 19, 2026
More news
Events and Presentations
SEC Filings
View Filings
Stock
REVB stock price
by TradingView
Summary
News
Events and Presentations
Filings
Stock